- Prognostic influences of B-cell lymphoma 2–positive expression on late recurrence in breast cancer
-
Kim HJ, Eom YH, Choi SH
- KMID: 2544609
- Ann Surg Treat Res.
- 2023 Jul;105(1):20-30.
- doi: 10.4174/astr.2023.105.1.20
Purpose: B-cell lymphoma 2 (BCL2) has an antiapoptotic role, however, has resulted in it being a powerful favorable prognostic factor in breast cancer. Several studies revealed BCL2 is strongly associated... -
- CITED
-
- Close
- SHARE
-
- Close
- Redo pull-through for postoperative complications following pull-through in Hirschsprung disease: a single center experience
-
Kwon YJ, Kwon H, Namgoong JM, Kim SC, Kim DY
- KMID: 2544613
- Ann Surg Treat Res.
- 2023 Jul;105(1):57-62.
- doi: 10.4174/astr.2023.105.1.57
Purpose: Although surgical management of Hirschsprung disease (HD) is effective in most patients, some patients experience long-term postoperative complications, and require redo pull-through (PT). The present study evaluated clinical outcomes... -
- CITED
-
- Close
- SHARE
-
- Close
- Recurrence in patients with totally necrotic nodules of hepatocellular carcinoma after liver transplantation: “totally” an inaccurate description
-
Kim J, Hong SK, Kim JY, Lee J, Choi HH, Lee S, Hong Sy, Lee JM, Choi Y, Yi NJ, Lee KW, Suh KS
- KMID: 2544612
- Ann Surg Treat Res.
- 2023 Jul;105(1):47-56.
- doi: 10.4174/astr.2023.105.1.47
Purpose: Total necrosis of hepatocellular carcinoma (HCC) achieved via locoregional treatment (LRT) is considered to indicate a lack of tumor viability. Nonetheless, there is insufficient evidence of recurrence after liver... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of abdominal aortic aneurysms in Korea: a nationwide study
-
Kim H, Kwon TW, Cho YP, Gwon JG, Han Y, Lee SA, Kim YJ, Kim S
- KMID: 2544611
- Ann Surg Treat Res.
- 2023 Jul;105(1):37-46.
- doi: 10.4174/astr.2023.105.1.37
Purpose: Although endovascular aneurysm repair (EVAR) has been shown to be superior to open surgical repair (OSR) for abdominal aortic aneurysm (AAA) treatment, no large-scale studies in the Korean population... -
- CITED
-
- Close
- SHARE
-
- Close
- Can chemotherapy be omitted for patients with N0 or N1 endocrine-sensitive breast cancer treated with gonadotropin-releasing hormone agonist and tamoxifen?
-
Lee J, Park CS, Oh JH, Park IC, Seong MK, Noh WC, Kim HA
- KMID: 2544610
- Ann Surg Treat Res.
- 2023 Jul;105(1):31-36.
- doi: 10.4174/astr.2023.105.1.31
Purpose: Whether administering chemotherapy followed by tamoxifen plus a gonadotropin-releasing hormone (GnRH) agonist to treat patients with lower-risk hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Survival analysis of breast cancer patients after diagnosis of second primary malignancies, focusing on the second primary hematologic malignancy
-
Kim HJ, Lee J, Park IC, Han Y, Seong MK, Noh WC, Kang HJ, Kim HA, Park CS
- KMID: 2544597
- Ann Surg Treat Res.
- 2023 Jul;105(1):1-9.
- doi: 10.4174/astr.2023.105.1.1
Purpose: Although the overall survival (OS) of breast cancer patients is increasing with improved detection and therapies, so is the risk of breast cancer patients developing subsequent malignancies. We investigated... -
- CITED
-
- Close
- SHARE
-
- Close
- Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study
-
Kim YJ, Kim HJ, Chung SY, Lee SK, Chae BJ, Yu J, Lee JE, Kim SW, Nam SJ, Ryu JM
- KMID: 2544598
- Ann Surg Treat Res.
- 2023 Jul;105(1):10-19.
- doi: 10.4174/astr.2023.105.1.10
Purpose: Based on the results of previous trials, de-escalation of axillary surgery after neoadjuvant chemotherapy (NAC) has increased in patients with axillary lymph node (ALN) metastasis at presentation. This study... -
- CITED
-
- Close
- SHARE
-
- Close
